11,000 Shares in HCA Healthcare, Inc. (NYSE:HCA) Purchased by Baltimore Washington Financial Advisors Inc.

Baltimore Washington Financial Advisors Inc. acquired a new position in HCA Healthcare, Inc. (NYSE:HCAGet Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 11,000 shares of the company’s stock, valued at approximately $26,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in HCA. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in shares of HCA Healthcare by 10.8% during the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 117,836 shares of the company’s stock valued at $29,940,000 after buying an additional 11,453 shares during the period. Wolf Group Capital Advisors boosted its stake in HCA Healthcare by 205.4% in the fourth quarter. Wolf Group Capital Advisors now owns 34,990 shares of the company’s stock worth $8,990,000 after buying an additional 23,533 shares in the last quarter. TD Asset Management Inc. boosted its stake in HCA Healthcare by 60.9% in the fourth quarter. TD Asset Management Inc. now owns 849,594 shares of the company’s stock worth $218,278,000 after buying an additional 321,524 shares in the last quarter. Cim Investment Management Inc. purchased a new stake in HCA Healthcare in the third quarter worth approximately $638,000. Finally, ProShare Advisors LLC boosted its stake in HCA Healthcare by 21.8% in the fourth quarter. ProShare Advisors LLC now owns 58,862 shares of the company’s stock worth $15,122,000 after buying an additional 10,528 shares in the last quarter. 67.87% of the stock is owned by institutional investors.

Shares of HCA Healthcare stock traded up $3.76 on Friday, reaching $215.55. The company had a trading volume of 1,640,638 shares, compared to its average volume of 1,775,485. The firm’s 50-day moving average price is $235.29 and its two-hundred day moving average price is $243.20. HCA Healthcare, Inc. has a 1 year low of $198.69 and a 1 year high of $279.02. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.43 and a quick ratio of 1.24. The firm has a market cap of $63.69 billion, a price-to-earnings ratio of 10.14, a P/E/G ratio of 1.30 and a beta of 1.61.

HCA Healthcare (NYSE:HCAGet Rating) last posted its quarterly earnings data on Friday, April 22nd. The company reported $4.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.27 by ($0.15). HCA Healthcare had a net margin of 11.40% and a return on equity of 405.72%. The business had revenue of $14.95 billion for the quarter, compared to analysts’ expectations of $14.72 billion. During the same quarter in the previous year, the firm earned $4.14 EPS. HCA Healthcare’s revenue was up 6.9% compared to the same quarter last year. As a group, analysts anticipate that HCA Healthcare, Inc. will post 17.15 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be issued a $0.56 dividend. This represents a $2.24 annualized dividend and a dividend yield of 1.04%. The ex-dividend date is Wednesday, June 15th. HCA Healthcare’s dividend payout ratio is 10.54%.

A number of brokerages recently commented on HCA. Wells Fargo & Company decreased their target price on HCA Healthcare from $267.00 to $227.00 and set an “equal weight” rating for the company in a report on Monday, April 25th. Truist Financial decreased their target price on HCA Healthcare from $310.00 to $250.00 and set a “buy” rating for the company in a report on Monday, April 25th. Citigroup decreased their price objective on HCA Healthcare from $277.00 to $254.00 and set a “buy” rating for the company in a report on Monday, April 25th. Royal Bank of Canada decreased their price objective on HCA Healthcare from $291.00 to $267.00 and set an “outperform” rating for the company in a report on Monday, April 25th. Finally, Cowen decreased their price objective on HCA Healthcare from $265.00 to $241.00 in a report on Monday, April 25th. Six investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Buy” and a consensus price target of $261.82.

In related news, SVP Kathleen M. Whalen sold 500 shares of the company’s stock in a transaction dated Tuesday, May 3rd. The stock was sold at an average price of $215.38, for a total transaction of $107,690.00. Following the transaction, the senior vice president now directly owns 11,373 shares of the company’s stock, valued at approximately $2,449,516.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Joseph A. Sowell III sold 11,522 shares of the company’s stock in a transaction dated Friday, March 11th. The shares were sold at an average price of $269.00, for a total value of $3,099,418.00. The disclosure for this sale can be found here. Over the last quarter, insiders acquired 91,370 shares of company stock valued at $19,373,375 and sold 14,380 shares valued at $3,723,203. 1.50% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.